Roche Products Pty Ltd—Viracept (nelfinavir)250 mg tablets, 50 mg oral powder

What are the defects?

Possible contamination of the active substance by an impurity called methane sulfonic acid ethyl ester in the active substance.

What are the hazards?

Potentially life threatening or could cause a serious risk to health.

What should consumers do?

Letters were dispatched to treating specialist physicians, pharmacies linked to HIV clinics, HIV Patient Advocacy Groups and wholesalers.

Roche Products Pty Ltd
Where the product was sold

Responsible regulator

Therapeutic Goods Administration is the responsible regulator for this recall.

Product category